Special Issue: Sudden Cardiac Death: Clinical Updates and Perspectives
Author Contributions
Funding
Conflicts of Interest
References
- Priori, S.G.; Blomström-Lundqvist, C.; Mazzanti, A.; Blom, N.; Borggrefe, M.; Camm, J.; Elliott, P.M.; Fitzsimons, D.; Hatala, R.; Hindricks, G.; et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 2015, 36, 2793–2867. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Feng, J.L.; Nedkoff, L.; Knuiman, M.; Semsarian, C.; Ingles, J.; Briffa, T.; Hickling, S. Temporal Trends in Sudden Cardiac Death From 1997 to 2010: A Data Linkage Study. Heart Lung Circ. 2017, 26, 808–816. [Google Scholar] [CrossRef] [PubMed]
- Maggioni, A.P.; Anker, S.D.; Dahlström, U.; Filippatos, G.; Ponikowski, P.; Zannad, F.; Amir, O.; Chioncel, O.; Leiro, M.C.; Drozdz, J.; et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur. J. Heart Fail. 2013, 15, 1173–1184. [Google Scholar] [CrossRef] [PubMed]
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999, 353, 9–13. [CrossRef]
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353, 2001–2007. [CrossRef]
- Yusuf, S.; Pitt, B.; Davis, C.E.; Hood, W.B.; Cohn, J.N. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 1991, 325, 293–302. [Google Scholar] [CrossRef]
- The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 1997, 336, 525–533. [CrossRef]
- Lee, D.S.; Mamdani, M.M.; Austin, P.C.; Gong, Y.; Liu, P.P.; Rouleau, J.L.; Tu, J.V. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am. J. Med. 2004, 116, 581–589. [Google Scholar] [CrossRef]
- Al-Khatib, S.M.; Stevenson, W.G.; Ackerman, M.J.; Bryant, W.J.; Callans, D.J.; Curtis, A.B.; Deal, B.J.; Dickfeld, T.; Field, M.E.; Fonarow, G.C.; et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2018, 72, e91–e220. [Google Scholar] [CrossRef]
- Stathopoulos, I.; Jimenez, M.; Panagopoulos, G.; Kwak, E.J.; Losquadro, M.; Cohen, H.; Iyer, S.; Ruiz, C.; Roubin, G.; Garratt, K. The decline in PCI complication rate: 2003–2006 versus 1999–2002. Hellenic. J. Cardiol. 2009, 50, 379–387. [Google Scholar]
- Rohde, L.E.; Chatterjee, N.A.; Vaduganathan, M.; Claggett, B.; Packer, M.; Desai, A.S.; Zile, M.; Rouleau, J.; Swedberg, K.; Lefkowitz, M.; et al. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis. JACC Heart Fail. 2020, 8, 844–855. [Google Scholar] [CrossRef] [PubMed]
- McMurray, J.J.; Packer, M.; Desai, A.S.; Gong, J.; Lefkowitz, M.P.; Rizkala, A.R.; Rouleau, J.L.; Shi, V.C.; Solomon, S.D.; Swedberg, K.; et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 2014, 371, 993–1004. [Google Scholar] [CrossRef] [Green Version]
- Kim, Y.G.; Han, K.; Jeong, J.H.; Roh, S.-Y.; Choi, Y.Y.; Min, K.; Shim, J.; Choi, J.-I.; Kim, Y.-H. Metabolic Syndrome, Gamma-Glutamyl Transferase, and Risk of Sudden Cardiac Death. J. Clin. Med. 2022, 11, 1781. [Google Scholar] [CrossRef] [PubMed]
- Shuvy, M.; Qiu, F.; Lau, G.; Koh, M.; Dorian, P.; Geri, G.; Lin, S.; Ko, D.T. Temporal trends in sudden cardiac death in Ontario, Canada. Resuscitation 2019, 136, 1–7. [Google Scholar] [CrossRef]
- Kuck, K.-H.; Cappato, R.; Siebels, J.; Rüppel, R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102, 748–754. [Google Scholar] [CrossRef] [Green Version]
- Behnes, M.; Akin, I.; Kuche, P.; Schupp, T.; Reiser, L.; Bollow, A.; Taton, G.; Reichelt, T.; Ellguth, D.; Engelke, N.; et al. Coronary chronic total occlusions and mortality in patients with ventricular tachyarrhythmias. EuroIntervention 2020, 15, 1278–1285. [Google Scholar] [CrossRef]
- Behnes, M.; Mashayekhi, K.; Weiß, C.; Nienaber, C.; Lang, S.; Reiser, L.; Bollow, A.; Taton, G.; Reichelt, T.; Ellguth, D.; et al. Prognostic Impact of Acute Myocardial Infarction in Patients Presenting With Ventricular Tachyarrhythmias and Aborted Cardiac Arrest. J. Am. Heart Assoc. 2018, 7, e010004. [Google Scholar] [CrossRef] [Green Version]
- Weidner, K.; Behnes, M.; Schupp, T.; Rusnak, J.; Reiser, L.; Taton, G.; Reichelt, T.; Ellguth, D.; Engelke, N.; Bollow, A.; et al. Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest. Clin. Res. Cardiol. 2019, 108, 669–682. [Google Scholar] [CrossRef]
- Akin, I.; Behnes, M.; Müller, J.; Forner, J.; Abumayyaleh, M.; Mashayekhi, K.; Akin, M.; Bertsch, T.; Weidner, K.; Rusnak, J.; et al. Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias. J. Clin. Med. 2022, 11, 2987. [Google Scholar] [CrossRef]
- Schupp, T.; Behnes, M.; Weiß, C.; Nienaber, C.; Lang, S.; Reiser, L.; Bollow, A.; Taton, G.; Reichelt, T.; Ellguth, D.; et al. Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia. Cardiovasc. Drugs Ther. 2018, 32, 353–363. [Google Scholar] [CrossRef] [PubMed]
- Schupp, T.; Behnes, M.; Abumayyaleh, M.; Weidner, K.; Mashayekhi, K.; Bertsch, T.; Akin, I. Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias. J. Clin. Med. 2022, 11, 1460. [Google Scholar] [CrossRef] [PubMed]
- Ohtsubo, T.; Shibata, R.; Kai, H.; Okamoto, R.; Kumagai, E.; Kawano, H.; Fujiwara, A.; Kitazono, T.; Murohara, T.; Arima, H. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: A systematic review and meta-analysis. Hypertens. Res. 2019, 42, 641–649. [Google Scholar] [CrossRef] [PubMed]
- Nojima, T.; Naito, H.; Obara, T.; Ageta, K.; Yakushiji, H.; Yumoto, T.; Fujisaki, N.; Nakao, A. Can Blood Ammonia Level, Prehospital Time, and Return of Spontaneous Circulation Predict Neurological Outcomes of Out-of-Hospital Cardiac Arrest Patients? A Nationwide, Retrospective Cohort Study. J. Clin. Med. 2022, 11, 2566. [Google Scholar] [CrossRef]
- Rysz, S.; Fagerlund, M.J.; Lundberg, J.; Ringh, M.; Hollenberg, J.; Lindgren, M.; Jonsson, M.; Djärv, T.; Nordberg, P. The Use of Levosimendan after Out-of-Hospital Cardiac Arrest and Its Association with Outcome—An Observational Study. J. Clin. Med. 2022, 11, 2621. [Google Scholar] [CrossRef] [PubMed]
- Yannopoulos, D.; Bartos, J.; Raveendran, G.; Walser, E.; Connett, J.; Murray, T.A.; Collins, G.; Zhang, L.; Kalra, R.; Kosmopoulos, M.; et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): A phase 2, single centre, open-label, randomised controlled trial. Lancet 2020, 396, 1807–1816. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Schupp, T.; Akin, I.; Behnes, M. Special Issue: Sudden Cardiac Death: Clinical Updates and Perspectives. J. Clin. Med. 2022, 11, 3120. https://doi.org/10.3390/jcm11113120
Schupp T, Akin I, Behnes M. Special Issue: Sudden Cardiac Death: Clinical Updates and Perspectives. Journal of Clinical Medicine. 2022; 11(11):3120. https://doi.org/10.3390/jcm11113120
Chicago/Turabian StyleSchupp, Tobias, Ibrahim Akin, and Michael Behnes. 2022. "Special Issue: Sudden Cardiac Death: Clinical Updates and Perspectives" Journal of Clinical Medicine 11, no. 11: 3120. https://doi.org/10.3390/jcm11113120